World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
99771
World Ranking
6631
National Ranking
3513

Overview

Stephen D. Wiviott is affiliated with Brigham and Women's Hospital in the United States. The main field of study covered by this scientist is Medicine, with a significant focus on cardiology, endocrinology, diabetes, and metabolism. The subfields of study include Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, and Genetics.

The scientist's research topics are centered mainly on diabetes treatment and management, metabolism related to diabetes and cancer, cardiovascular function and risk factors, lipoproteins and cardiovascular health, pancreatic function and diabetes, acute myocardial infarction research, and heart failure treatment and management.

Stephen D. Wiviott has published extensively, with frequent contributions appearing in the following journals:

  • Circulation
  • Journal of the American College of Cardiology
  • JAMA Cardiology
  • European Heart Journal
  • Diabetes Obesity and Metabolism

Some recent papers include the full titles, years of publication, and venues:

  • Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus, 2020, Circulation
  • Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV, 2024, JAMA Cardiology
  • Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease, 2021, European Heart Journal
  • Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines, 2020, JAMA Cardiology
  • Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes, 2023, JAMA Cardiology

Frequent co-authors collaborating with Stephen D. Wiviott include:

  • Marc S. Sabatine
  • Deepak L. Bhatt
  • Itamar Raz
  • David A. Morrow
  • Darren K. McGuire

Best Publications

  • Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

    Stephen D. Wiviott;Eugene Braunwald;Carolyn H. McCabe;Gilles Montalescot

  • Edoxaban versus warfarin in patients with atrial fibrillation

    Robert P. Giugliano;Christian T. Ruff;Eugene Braunwald;Sabina A. Murphy

  • Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

    Marc S. Sabatine;Robert P. Giugliano;Anthony C. Keech;Narimon Honarpour

  • Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium

    Roxana Mehran;Sunil V. Rao;Deepak L. Bhatt;C. Michael Gibson

  • Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

    Benjamin M. Scirica;Deepak L. Bhatt;Deepak L. Bhatt;Eugene Braunwald;P. Gabriel Steg

  • Cytochrome P-450 Polymorphisms and Response to Clopidogrel

    Jessica L. Mega;Sandra L. Close;Stephen D. Wiviott;Lei Shen

  • SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

    Thomas A Zelniker;Stephen D Wiviott;Itamar Raz;Kyungah Im

  • Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

    Jessica L. Mega;Eugene Braunwald;Stephen D. Wiviott;Jean-Pierre Bassand

  • Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

    Marc P. Bonaca;Deepak L. Bhatt;Marc Cohen;Philippe Gabriel Steg

  • Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

    Laura Mauri;Dean J. Kereiakes;Robert W. Yeh;Priscilla Driscoll-Shempp

  • Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes: Phase Z of the A to Z Trial

    James A de Lemos;Michael A. Blazing;Stephen D. Wiviott;Eldrin F. Lewis

  • Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.

    Gilles Montalescot;Stephen D Wiviott;Eugene Braunwald;Sabina A Murphy

  • Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.

    Jessica L. Mega;Tabassome Simon;Jean Philippe Collet;Jeffrey L. Anderson

  • Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis

    Michael G. Silverman;Brian A. Ference;Kyungah Im;Stephen D. Wiviott

  • Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.

    Stephen D. Wiviott;Dietmar Trenk;Andrew L. Frelinger;Michelle O’Donoghue

  • Vorapaxar in the secondary prevention of atherothrombotic events

    David A. Morrow;Eugene Braunwald;Marc P. Bonaca;Sebastian F. Ameriso

  • Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

    Hps;Louise Bowman;Jemma C Hopewell

  • Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

    Stephen D. Wiviott;Eugene Braunwald;Dominick J. Angiolillo;Simha Meisel

  • Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

    M.S. Sabatine;R.P. Giugliano;S.D. Wiviott

  • Cytochrome P-450 Polymorphisms and Response to Clopidogrel

    J.L. Mega;S.L. Close;S.D. Wiviott

Frequent Co-Authors

Eugene Braunwald
Eugene Braunwald Harvard Medical School
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Sabina A. Murphy
Sabina A. Murphy Brigham and Women's Hospital
Elliott M. Antman
Elliott M. Antman Brigham and Women's Hospital
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Christopher P. Cannon
Christopher P. Cannon Brigham and Women's Hospital
David A. Morrow
David A. Morrow Brigham and Women's Hospital
Robert P. Giugliano
Robert P. Giugliano Brigham and Women's Hospital
Matthew T. Roe
Matthew T. Roe Duke University
Darren K. McGuire
Darren K. McGuire The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can be a practical alternative for students interested in healthcare careers but who are not ready to commit to a traditional medical school path. Flexible and often more affordable, these programs allow you to develop specialized skills and enter the workforce quickly.

For those drawn to pharmaceuticals, consider options like online pharmacy school programs that offer advanced training for pharmacists while allowing you to study at your own pace. If your interests are behind the scenes in managing medical records, an him associate degree online provides the foundation for a career in Health Information Management.

Medical billing and coding is another growing area, with many asking how much is medical billing and coding school due to its affordability and job prospects. Nursing remains a high-demand field, and you can begin your path with cheap online fnp programs to qualify as a Family Nurse Practitioner.

Pursuing these online healthcare degrees can lead to rewarding careers while providing flexibility and potential cost savings.

Best Scientists Citing Stephen D. Wiviott

Trending Scientists